These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 17484225

  • 21. [Persistant fever and generalized scaly rash in a 3 year-old female child. Kawasaki disease with coronary aneurysms].
    Bernal Ruiz AI, González Ruiz A, Blanco Eguren G, García Muñoz M.
    Rev Clin Esp; 2001 Apr; 201(4):217-8. PubMed ID: 11447911
    [No Abstract] [Full Text] [Related]

  • 22. Outcome of coronary artery aneurysms after Kawasaki disease.
    Akagi T, Rose V, Benson LN, Newman A, Freedom RM.
    J Pediatr; 1992 Nov; 121(5 Pt 1):689-94. PubMed ID: 1432415
    [Abstract] [Full Text] [Related]

  • 23. Progressive Coronary Dilatation Predicts Worse Outcome in Kawasaki Disease.
    Chih WL, Wu PY, Sun LC, Lin MT, Wang JK, Wu MH.
    J Pediatr; 2016 Apr; 171():78-82.e1. PubMed ID: 26852179
    [Abstract] [Full Text] [Related]

  • 24. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group.
    Fernandez-Cooke E, Barrios Tascón A, Sánchez-Manubens J, Antón J, Grasa Lozano CD, Aracil Santos J, Villalobos Pinto E, Clemente Garulo D, Mercader Rodríguez B, Bustillo Alonso M, Nuñez Cuadros E, Navarro Gómez ML, Domínguez-Rodríguez S, Calvo C, KAWA-RACE study group.
    PLoS One; 2019 Apr; 14(5):e0215665. PubMed ID: 31107862
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
    Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED.
    Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838
    [Abstract] [Full Text] [Related]

  • 26. Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.
    Bachlava E, Loukopoulou S, Karanasios E, Chrousos G, Michos A.
    Int J Cardiol; 2016 Oct 01; 220():65-9. PubMed ID: 27372045
    [Abstract] [Full Text] [Related]

  • 27. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 01; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 28. Giant coronary artery aneurysms in a 12-week-old infant with incomplete Kawasaki disease.
    Guile L, Parke S, Kelly A, Tulloh R.
    BMJ Case Rep; 2018 Mar 28; 2018():. PubMed ID: 29593004
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cardiac complications in children with Kawasaki disease in our own experience.
    Gowin E, Małecka I, Stryczyńska-Kazubska J, Michalak M, Wysocki J, Górzna-Kamińska H.
    Kardiol Pol; 2016 Mar 28; 74(1):75-82. PubMed ID: 26202530
    [Abstract] [Full Text] [Related]

  • 31. Using nomogram scores to predict the early regression of coronary artery aneurysms of Kawasaki disease.
    He Y, Shao S, Qiao Y, Zhang N, Gong X, Hua Y, Zhou K, Li Y, Liu X, Wang C.
    Cardiol Young; 2024 Feb 28; 34(2):348-355. PubMed ID: 37424509
    [Abstract] [Full Text] [Related]

  • 32. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.
    Okubo Y, Nochioka K, Sakakibara H, Testa M, Sundel RP.
    Clin Rheumatol; 2017 Feb 28; 36(2):413-419. PubMed ID: 27987089
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?
    Williams RV, Wilke VM, Tani LY, Minich LL.
    Pediatrics; 2002 Jan 28; 109(1):E4. PubMed ID: 11773572
    [Abstract] [Full Text] [Related]

  • 36. [Incomplete Kawasaki syndrome with a coronary artery aneurysm in an infant].
    Vinding RK, Debes NM, Stantchev H, Vrang C, Orngreen MC.
    Ugeskr Laeger; 2014 Jun 16; 176(25):. PubMed ID: 25352282
    [Abstract] [Full Text] [Related]

  • 37. [Kawasaki disease in 76 patients. Risk factors for coronary artery aneurysms].
    Caballero-Mora FJ, Alonso-Martín B, Tamariz-Martel-Moreno A, Cano-Fernández J, Sánchez-Bayle M.
    An Pediatr (Barc); 2011 Apr 16; 74(4):232-8. PubMed ID: 21296631
    [Abstract] [Full Text] [Related]

  • 38. [Giant coronary aneurysms in infants with Kawasaki disease].
    Sánchez Andrés A, Salvador Mercader I, Seller Moya J, Carrasco Moreno JI.
    An Pediatr (Barc); 2017 Aug 16; 87(2):65-72. PubMed ID: 27649630
    [Abstract] [Full Text] [Related]

  • 39. Polyarteritis nodosa (PAN) with coronary aneurysms: the kawasaki-PAN controversy revisited.
    Bowyer S, Mason WH, McCurdy DK, Takahashi M.
    J Rheumatol; 1994 Aug 16; 21(8):1585. PubMed ID: 7983675
    [No Abstract] [Full Text] [Related]

  • 40. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.
    Rowley AH, Duffy CE, Shulman ST.
    J Pediatr; 1988 Aug 16; 113(2):290-4. PubMed ID: 2456378
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.